Abstract:Abstract Decorin is a small leucine-rich proteoglycan. Previous studies have demonstrated that decorin expression is significantly reduced in colorectal cancer tissues and cancer cells, and genetic deletion of the decorin gene caused intestinal tumor formation in mice, which was linked to a downregulation of p21, p27kip1 and E-cadherin and an upregulation of β-catenin signaling. However, the regulation of E-cadherin by decorin and its implication in cancer formation and metastasis is largely unknown. Using manipulated colorectal cancer cells and decorin knockout mouse model (Dcn-/- mice), we found that increasing decorin expression in colorectal cancer cells delayed cancer cell growth, accelerated apoptosis, and importantly, attenuated cancer cell migration, invasion and wound healing. Mechanistic study revealed that the attenuation of cancer cell malignancy was resulted from the interaction between decorin and E-cadherin, a protein that regulates cell-cell adhesion, epithelial-mesenchymal transition and metastasis. First, overexpression of decorin led to upregulation of E-cadherin through increasing of E-cadherin protein stability, while E-cadherin mRNA and promoter activity were not affected; Second, co-immunoprecipitation assay showed that decorin physically bound E-cadherin. In addition, the upregulation of E-cadherin was associated with reduction of β-catenin, c-myc and CDK4. cDNA microarray analysis also showed that the levels of two proteins involved in metastasis were altered, the extracellular proteinase inhibitor (EXPI) was significantly downregulated and Claudin 2 was upregulated in intestinal epithelial cells of the Dcn-/- mice. Moreover, loss of decorin accelerated murine cancer cell MC38 growth and invasion in the flank of Dcn-/- mice. Taken together, our results provide direct evidence that decorin-mediated inhibition of colorectal cancer formation and metastasis is through the interaction between decorin and E-cadherin/beta-catenin signaling. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1448. doi:10.1158/1538-7445.AM2011-1448

Mechanism of Decorin Protein Inhibiting Invasion and Metastasis of Non-Small Cell Lung Cancer.

Decorin is Responsible for Progression of Non-Small-cell Lung Cancer by Promoting Cell Proliferation and Metastasis

Effects and Mechanism of Decorin on the Proliferation of A549 Lung Adenocarcinoma Cells in Vitro

Human decorin regulates proliferation and migration of human lung cancer A549 cells.

Decorin suppresses stemness and migration potential of malignant peripheral nerve sheath tumor through inhibiting epidermal growth factor receptor signaling

Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

Decorin Knockdown Affects The Gene Expression Profile Of Adhesion, Growth And Extracellular Matrix Metabolism In C-28/I2 Chondrocytes

Biological Functions of Decorin in Cancer

[Mechanisms of Decorin Inhibiting Epithelial-to-mesenchymal Transition Induced by Transforming Growth Factor Beta1 in Renal Tubular Epithelial Cells].

Study on expressions of Decorin mRNA、 p57~(KIP2) mRNA and TGF-β1 and their clinical significance in lung cancer

Abstract 1448: Interaction Between Decorin and E-cadherin/beta-catenin Signaling Attenuates Colorectal Cancer Growth and Metastasis in Vitro and in Decorin Knockout Mice

Biological functions of decorin in cancer.

Decorin-Mediated Inhibition of Colorectal Cancer Growth and Migration is Associated with E-Cadherin in Vitro and in Mice

Effect of Decorin Gene Overexpression on Migration and Invasion of Cholangiocarcinoma Cells

Expression of Decorin in Cholangiocarcinoma and Clinical Implication

Decorin deficiency promotes epithelial-mesenchymal transition and colon cancer metastasis

The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma

Decreased Expression of Decorin and P57(Kip2) Correlates with Poor Survival and Lymphatic Metastasis in Lung Cancer Patients

Recombinant decorin ameliorates the pulmonary structure alterations by down-regulating transforming growth factor-β1Smads signaling in the diabetic rats

[The Action of Decorin in Anti-Fibrosis and Anti-Cancer].

Reduced decorin expression in the tumor stroma correlates with tumor proliferation and predicts poor prognosis in patients with I–IIIA non-small cell lung cancer